Skip to main content
Figure 3 | Respiratory Research

Figure 3

From: Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations

Figure 3

Time from antibiotic treatment initiation to peak FEV 1 measure for subgroups. Panel A, Time to peak FEV1 measure stratified by antibiotic treatment assignment. Gray line, ceftaz/tobra; black line, mero/tobra; dotted line, population treatment duration. Panel B. Time to peak FEV1 measure stratified by baseline lung function. Gray line, patients with baseline FEV1 ≥ 70% predicted, black line, patients with baseline FEV1 between 40% and 69% predicted; dashed line, patients with baseline FEV1 < 40% predicted; dotted line, population treatment duration.

Back to article page